Harvard-trained gastroenterologist Dr. Saurabh Sethi highlights common habits silently harming gut health. Eating too fast ...

Excess use of over-the-counter medications is the second-leading cause of peptic ulcers, which cause stomach pain.

Medically reviewed by Mary Choy, PharmD Your kidneys may be small in size, but they play an important role in the body. Kidneys remove waste, extra fluid, and acids, maintaining a balance of water, ...

Certain medications like antibiotics, diuretics, immunosuppressants, and NSAIDs can increase sun sensitivity, leading to severe sunburns and higher skin cancer risks. Protect your skin by using ...

You should avoid taking nonsteroidal anti-inflammatory drugs, or NSAIDs — such as ibuprofen, naproxen and aspirin — whenever possible. If you do need to take them, use the smallest dose for ...

Nonsteroidal anti-inflammatory drugs (NSAIDs) help reduce pain and inflammation. A list of common NSAIDs includes ibuprofen, aspirin, and naproxen. Though there are a variety of different NSAIDs ...

Constipation is a potential side effect of numerous medications, including antidepressants, antihistamines, blood pressure medication, and nonsteroidal anti-inflammatory drugs (NSAIDs) like ...

Humans have had an insatiable appetite for inhibiting production of prostaglandins for centuries! This series delves into the history of aspirin and NSAIDs, looking at the understanding of the ...

By Paul McClure January 01, 2024 Researchers have developed a plant-derived non-steroidal anti-inflammatory that does not weaken the innate immune system like existing drugs Depositphotos View 1 ...

The global non-steroidal anti-inflammatory drugs market is expected to grow from $18.27 billion in 2022 to $19.57 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The non-steroidal ...

Nonsteroidal anti-inflammatory drugs inhibit the cyclooxygenase enzyme, reducing inflammation and pain. Compared with oral formulations, topical NSAIDs work locally, with systemic uptake limited to ...

The global non-steroidal anti-inflammatory drugs market is expected to grow from $18.27 billion in 2022 to $19.57 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%.